We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Illumina Launches First CE-Marked Genomic Profiling Test for Cancer
Illumina Launches First CE-Marked Genomic Profiling Test for Cancer
Illumina has launched its cancer diagnostic test, TruSight Oncology (TSO) Comprehensive (EU), in Europe — calling it the first CE-marked in vitro diagnostic (IVD) kit for comprehensive genomic profiling based on DNA and RNA content.